X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TEVA PHARMA (Israel) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   TEVA PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TEVA PHARMA
Dec-13
STERLING BIOTECH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs112,979-   
Low Rs32,588-   
Sales per share (Unadj.) Rs26.81,709.7-  
Earnings per share (Unadj.) Rs-15.0106.8-  
Cash flow per share (Unadj.) Rs-5.5245.0-  
Dividends per share (Unadj.) Rs093.49-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs54.91,899.1-  
Shares outstanding (eoy) m267.87848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 15.9%   
Avg P/E ratio x-0.526.1 -1.8%  
P/CF ratio (eoy) x-1.311.4 -11.2%  
Price / Book Value ratio x0.11.5 8.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,8622,360,349 0.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.332,257.4 16.4%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,015.1 -146.8%   
INCOME DATA
Net Sales Rs m7,1811,449,810 0.5%  
Other income Rs m430-   
Total revenues Rs m7,2231,449,810 0.5%   
Gross profit Rs m947397,031 0.2%  
Depreciation Rs m2,543117,190 2.2%   
Interest Rs m4,37728,477 15.4%   
Profit before tax Rs m-5,931251,365 -2.4%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,007 0.0%   
Tax Rs m-1,924-3,069 62.7%   
Profit after tax Rs m-4,00790,569 -4.4%  
Gross profit margin %13.227.4 48.2%  
Effective tax rate %32.4-1.2 -2,657.5%   
Net profit margin %-55.86.2 -893.2%  
BALANCE SHEET DATA
Current assets Rs m14,335979,196 1.5%   
Current liabilities Rs m49,809853,942 5.8%   
Net working cap to sales %-494.08.6 -5,718.3%  
Current ratio x0.31.1 25.1%  
Inventory Days Days40391 444.3%  
Debtors Days Days17196 177.9%  
Net fixed assets Rs m55,432473,540 11.7%   
Share capital Rs m2683,569 7.5%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7011,610,464 0.9%   
Long term debt Rs m9,478741,320 1.3%   
Total assets Rs m73,9883,313,281 2.2%  
Interest coverage x-0.49.8 -3.6%   
Debt to equity ratio x0.60.5 140.1%  
Sales to assets ratio x0.10.4 22.2%   
Return on assets %0.53.6 13.9%  
Return on equity %-27.35.6 -484.6%  
Return on capital %-6.44.9 -130.3%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719231,025 0.7%  
From Investments Rs m-3,148-81,861 3.8%  
From Financial Activity Rs m1,426-277,130 -0.5%  
Net Cashflow Rs m-3-127,966 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare STERLING BIOTECH With: PIRAMAL ENTERPRISES  FULFORD INDIA  CIPLA  J.B.CHEMICALS  PFIZER  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - WOCKHARDT LTD. COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS